What is the purpose of this trial?
This research study is designed to look at the involvement of the glutamate system in depression. Each subject will undergo a screening appointment to determine study eligibility. Thereafter, the study will take 2 or 3 visits depending on schedule availability and will consist of one MRI scan, and PET scan. Subjects will also participate in cognitive testing. Depending on camera time, staff availability and subject schedule, total study participation may last 1-2 months.
Ages: 18 - 65 years
Yale University School of Medicine
Start Date: 08/23/2011
End Date: 08/22/2021
Last Updated: 12/12/2018
Study HIC#: 1101007933